Pipeline

Orphan drug sales expected to grow 12% by 2020

Click for an infographic to learn more about orphan drugs, rare diseases and the top-selling drugs in the category.

February 3, 2016

12:00 pm

From the February 01, 2016 Issue of MM+M - Medical Marketing and Media

From Our Partners

Partner Content

Caregivers need pharma’s help. What can the industry do?

Caregivers are physically, financially and emotionally drained and don’t feel equipped or qualified to provide optimal care. How can pharma better support them?

Partner Content

Attracting and retaining top talent amidst the Great Reshuffle

Kimberly Jones, President & CEO of Butler/Till, talks with Marc Iskowitz about how her company is thriving, despite an incredibly tight job market and the ever-evolving marketing ecosystem.

Partner Content

The value of omnichannel marketing for pharma

MM+M’s GM Steve Madden sat down with Louis Naimoli, director of programmatic for Haylo, a subsidiary of Haymarket Medical Network, to discuss omnichannel marketing, its prevalence in the pharma industry, and more.

Partner Content

HCP engagement in 2022 — The HLD HCP Communications Report

Healthlink Dimensions’ 2022 Communications Report — your guide for provider-based insights into HCP marketing outreach as COVID continues to reshape the industry.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Orphan drug sales expected to grow 12% by 2020

Places to Be 2021

From Our Partners

Partner Content

Caregivers need pharma’s help. What can the industry do?

Partner Content

Attracting and retaining top talent amidst the Great Reshuffle

Partner Content

The value of omnichannel marketing for pharma

Partner Content

HCP engagement in 2022 — The HLD HCP Communications Report

Thank you for accessing MM+M.